

Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.476, 2005-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Statins poor contenders for OTC status, says expert
Inpharma, Vol. 1, Iss. 1483, 2005-01 ,pp. :


Use of statins poor in the ambulatory setting
Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. :


Statins: stick to the status quo?
Inpharma, Vol. 1, Iss. 1262, 2000-01 ,pp. :


Monitoring CV status in fingolimod patients crucial, says Novartis
Reactions Weekly, Vol. 1, Iss. 1388, 2012-01 ,pp. :